Death from respiratory depression may result from toxicity of which class of drugs?

Narcotics, also known as opioids, are primarily associated with the risk of respiratory depression, particularly in cases of overdose or toxicity. These medications work by binding to opioid receptors in the brain, which can suppress the central nervous system's drive to breathe. When taken in excessive amounts, opioids can lead to a significant decrease in respiratory rate and depth, ultimately resulting in inadequate ventilation and oxygenation of the body.

This is a critical point of concern in clinical settings, particularly when narcotics are prescribed for pain management or during situations where patients may not be tolerant to their effects. Additionally, individuals who combine narcotics with other CNS depressants, such as benzodiazepines or alcohol, are at an even higher risk for respiratory depression.

Understanding the risks associated with narcotics is essential for pharmacy technicians as they play a crucial role in patient safety by recognizing signs of potential overdose or adverse effects related to these medications.